Key facts
- Ride Health’s last known valuation is $50.5M (Dec 2025).
- It has raised $31.4M across 2 recorded rounds; the latest was Early Stage VC ($15.5M) in Nov 2024.
- Notable investors include nvp capital, Oxeon Partners, BioAdvance Capital (Conshohocken), Activate Venture Partners, Actions Capital — 15 tracked in total.
- Ride Health has filed 3 Form Ds with the SEC since 2021, most recently Dec 2025 ($15.5M sold to 21 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Ride Health
Funding rounds
2 roundsAbout Ride Health
Developer of a healthcare transportation management platform intended to improve access to care for patients who face transportation barriers. The company partners with healthcare organizations and transportation providers to allow clients to manage transportation benefits, strengthen enterprise transportation programs, and drive intelligent transitions of care through an integrated platform, enabling healthcare providers to offer patients greater access, improved efficiencies, lower costs, and better outcomes.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2016
- Employees
- 47
- Website
- ridehealth.com/
- Ownership
- Privately Held (backing)
Ride Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ride Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ride Health in its N-PORT filings yet. We sweep new filings monthly.